Deng, R., Zhang, W., Lv, J., Wang, F., Chen, Y., Jiang, C., . . . Zhang, C. (2024). Afatinib as first-line treatment for advanced lung squamous cell carcinoma harboring uncommon EGFR G719C and S768I co-mutation. Heliyon, 10(15), . https://doi.org/10.1016/j.heliyon.2024.e35304
Chicago-referens (17:e uppl.)Deng, Ruoyu, Wen Zhang, Jialing Lv, Fang Wang, Yanqiong Chen, Chengqi Jiang, Yaling Guan, och Chao Zhang. "Afatinib as First-line Treatment for Advanced Lung Squamous Cell Carcinoma Harboring Uncommon EGFR G719C and S768I Co-mutation." Heliyon 10, no. 15 (2024). https://doi.org/10.1016/j.heliyon.2024.e35304.
MLA-referens (9:e uppl.)Deng, Ruoyu, et al. "Afatinib as First-line Treatment for Advanced Lung Squamous Cell Carcinoma Harboring Uncommon EGFR G719C and S768I Co-mutation." Heliyon, vol. 10, no. 15, 2024, https://doi.org/10.1016/j.heliyon.2024.e35304.
